Revolutionizing Brain Tissue Modeling: A Fully Animal-Free Approach
Breakthrough in Growing Brain Tissue Models Using Fully Animal-Free Materials
Scientists have achieved a remarkable feat in the field of neural tissue engineering by developing a groundbreaking method to cultivate functional, brain-like tissue without the need for any animal-derived materials or biological coatings. This innovation paves the way for more controlled and humane neurological drug testing, marking a significant advancement in the pursuit of replicating the human brain's structure and function.
The primary objective of neural tissue engineering is to create a model that closely resembles the human brain, enabling more reproducible studies of neurological diseases and drug testing. However, traditional brain tissue platforms often rely on biological coatings derived from animals, which can be challenging to replicate accurately for reliable testing. Iman Noshadi, a UCR associate professor of bioengineering and the team leader, highlights this issue, stating, 'One of the drawbacks of most brain tissue platforms is that they utilize biological coatings to help living cells thrive. These animal-derived coatings are poorly defined, which makes it difficult to recreate their exact composition for reliable testing.'
Furthermore, the current practice of using animal brains for research relevant to human conditions is not ideal due to significant genetic and physiological differences between rodent and human brains. This new platform has the potential to reduce and, in some cases, eliminate the reliance on animal brains for such research, aligning with the U.S. FDA's efforts to phase out animal testing requirements in drug development.
The new material, detailed in the Advanced Functional Materials journal, serves as a scaffold for growing donor brain cells and can be utilized to model traumatic brain injuries, strokes, or neurological diseases like Alzheimer's. It is primarily composed of a common polymer known for its chemical neutrality, polyethylene glycol (PEG). Typically, living cells do not attach to PEG without the addition of proteins like laminin or fibrin.
The research team addressed this challenge by reshaping PEG into a maze of textured, interconnected pores, transforming an inert material into a matrix that cells recognize, colonize, and use to build functional neural networks. Once these cells mature, they can exhibit donor-specific neural activity, enabling direct evaluation of drugs targeted to their neurological conditions. Prince David Okoro, the study's lead author and a doctoral candidate in Noshadi's lab, emphasizes the significance of this stability, stating, 'Since the engineered scaffold is stable, it permits longer-term studies. That's especially important as mature brain cells are more reflective of real tissue function when investigating relevant diseases or traumas.'
The scaffold structure was built using a process involving water, ethanol, and PEG flowing through nested glass capillaries. When the mixture reached an outer water stream, its components began to separate. A flash of light stabilized this separation, locking in the porous structure. The pores within the scaffold allow for efficient circulation of oxygen and nutrients, essentially feeding the donated stem cells.
Noshadi explains, 'The material ensures cells get what they need to grow, organize, and communicate with each other in brain-like clusters. Because the structure more closely mimics biology, we can start to design tissue models with much finer control over how cells behave.'
The research, initiated in 2020, was supported by Noshadi's startup funds from UC Riverside, while Okoro's work was funded by the California Institute for Regenerative Medicine. Currently, the scaffold material is approximately two millimeters wide, and the team is working on scaling the model, having submitted a related paper focused on liver tissue.
Looking ahead, the group aims to develop a suite of interconnected organ-level cultures that reflect the interactions between systems in the body. They aspire for these tissue platforms to offer stability, longevity, and functionality comparable to the brain tissue model, marking a significant step toward understanding human biology and disease in a more integrated manner.
Controversy & Comment Hooks:
While this breakthrough is undoubtedly exciting, it also raises questions about the future of animal-based research. Some may argue that while this approach is more controlled and humane, it may not fully replicate the complexity of animal brains. Others might wonder if the scalability of this model will be sufficient to meet the demands of pharmaceutical testing. What do you think? Do you agree or disagree with this interpretation? Share your thoughts in the comments below!
